TITLE

Is liver transplant for alcohol-related end-stage liver disease appropriate?

AUTHOR(S)
Bailey, Deborah; Pathak, Samir; Ahmad, Niaz
PUB. DATE
August 2013
SOURCE
British Journal of Hospital Medicine (17508460);Aug2013, Vol. 74 Issue 8, p439
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the appropriateness of liver transplant for alcohol-related end-stage liver disease. It also dicusses the priority for patients, who are self-responsble for their disease and also expands on genetic and social aspects of alcoholism. It also dicusses failure in seeking timely help by patients and mental health problems associated with patients with the disease. It also partially hold patients responsible for enging themselves in behavior that lead to these poor conditions.
ACCESSION #
89797602

 

Related Articles

  • Liver transplantation for fulminant hepatic failure. Van Thiel, David H.; Brems, John; Nadir, Abdul; Idilman, Ramazan; Colantoni, Alessandra; Holt, David; Edelstein, Steven // Journal of Gastroenterology;2001, Vol. 36 Issue 1, p1 

    Focuses on liver transplantation as treatment for fulminant hepatic failure. Definition of fulminant hepatic failure; Etiology and prognosis of the disease; Medical management of patients with fulminant hepatic failure; Systems for the identification of those who will require liver transplantation.

  • Think-tank report condemns IAPT 'monoculture'  // Therapy Today;May2012, Vol. 23 Issue 4, p10 

    The article reports the findings of "Commissioning Effective Talking Therapies", a controversial report by the Centre for Social Justice, an independent thinktank that patients are unable to access alternative therapies that might be more because doctors cannot refer them outside IAPT.

  • Efavirenz/emtricitabine/tenofovir disoproxil fumarate.  // Reactions Weekly;9/14/2013, Issue 1469, p21 

    An abstract of the article "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser," by A. M. Elsharkawy and colleagues is presented.

  • Ethical Considerations of Transplantation and Living Donation for Patients with Alcoholic Liver Diseases. Singhvi, Ajay; Welch, Alexandra N.; Levitsky, Josh; Singhvi, Deepti; Gordon, Elisa J. // AMA Journal of Ethics;Feb2016, Vol. 18 Issue 2, p163 

    The article reflects on ethical issues related to organ transplantation and donation of organs by living person for patients with alcoholic liver disease; and discusses social stigma of the patient with the disease.

  • Neighborhood Characteristics Associated With Access To Patient-Centered Medical Homes For Children. Aysola, Jaya; Orav, E. John; Ayanian, John Z. // Health Affairs;Nov2011, Vol. 30 Issue 11, p2080 

    Understanding social determinants of health, such as the social and physical conditions under which children and their families live, work, and play, is essential to reducing disparities and improving the quality of primary care. We studied the relationship between perceptions of neighborhood...

  • Clinical outcomes of right-lobe split-liver versus orthotopic liver transplants from donors more than 70 years old. Memeo, Riccardo; de'Angelis, Nicola; Salloum, Chady; Compagnon, Philipe; Laurent, Alexis; Feray, Cyrille; Duvoux, Cristoph; Azoulay, Daniel // Progress in Transplantation;Sep2015, Vol. 25 Issue 3, p243 

    Context--The imbalance between the organ supply and the number of potential transplant recipients led to consideration of expanded-criteria liver donors. Objective--To compare right-lobe split-liver transplants (RL-SLTs) with orthotopic liver transplants (OLTs) from donors more than 70 years old...

  • VITAGEN ANNOUNCES ENROLLMENT FOR PHASE II TRIAL OF ELAD(r) BIOARTIFICIAL LIVER SUPPORT THERAPY. Stern, Aron // Internet Journal of Radiology;2003, Vol. 3 Issue 1, p5 

    The pharmaceutical company VitaGen Inc. has announced enrollment for phase II trial of ELAD(r) bioartificial liver support therapy for patients with fulminant hepatic failure. It is the first human cell-based bioartificial liver system designed to increase the liver's ability to regenerate and...

  • KaraciÄŸer YetersizliÄŸinde Uygulanan Ekstrakorporeal Destek Sistemlerinin Etkileri. Şentürk, Evren; Ergin Özcan, Perihan; Orhun, Günseli; Pınarbaşı, Binnur; Esen, Figen; Telci, Lütfi; Çakar, Nahit // Journal of the Turkish Anaesthesiology & Intensive Care Society ;Sep/Oct2012, Vol. 40 Issue 5, p269 

    Objective: Extracorporeal liver support systems represent an important option for the treatment of liver failure. In this retrospective study, effects of two different support systems were examined, and these systems were compared. Methods: Molecular Absorbent Recirculating System (MARS) (10...

  • Research advances in oxidative stress and mitochondrial permeability transition in liver failure. WANG Kefei; ZHU Yueke; MENG Qinghua // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;sep2013, Vol. 29 Issue 9, p711 

    Major treatment options for liver failure include clinical medical treatment, and prevention of complications), artificial liver, liver transplantation, and stem cell transplantation. While these means are known to have produced favorable outcomes, some patients died due to acute and severe...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics